Background & Objectives: Aorto-bi-femoral 
Introduction:
Although the advent of interventional treatments has brought a paradigm shift in the management approach to aorto-iliac occlusive diseases (AIOD), 1, 2 conventional surgical revascularization still occupies an important place in this patient subgroup. Among the surgical strategies adopted to revascularize the occluded aorto-iliac segment, aorto-bi-femoral bypass with Y-graft is considered the 'gold standard'. 3, 4 The approach is generally advocated in patients having lesions that are considered unsuitable for Percutaneous Transluminal Angioplasty (PTA).
Such lesions include bilateral, multifocal long segment stenosis or occlusion. Symptomatic patients with this type of lesions benefit from open surgical revascularization. However, the results of aorto-bi-femoral bypass with Y-graft have been variable. Many of these patients are 'arteriopaths' and therefore, have a generalized atherosclerotic process with cardiovascular and cerebrovascular manifestations. The presence of other risk factors and comorbidities like diabetes mellitus, hypertension, and cigarette smoking often contribute to major post-operative complications in the form of graft failure and cardiovascular and cerebrovascular events. While there have been a lot of reports from developed countries describing the surgical experience with aorto-bifemoral bypass, [3] [4] [5] [6] contributions from developing countries have been rather few. We undertook this study to analyze our recent experiences with this procedure.
Materials and Methods:
Over a period of 3 years (April 2008 to March 2011), a total of 47 patients underwent aorto-bi-femoral or aorto-bisiliac bypass grafting for aorto-iliac occlusive disease at the National Institute of Cardiovascular Diseases (NICVD), Dhaka using a Y-graft prosthesis. The mean age of these patients was 46.4 years (range 25-75 years). Thirty eight of the patients were male and the remaining 9 were female. Various clinical presentations of the patients are summarized in Table-I . Risk factors and co-morbid conditions found in these patients are listed in Table- II. Lesions suitable for interventional treatment were set aside for PTA, while those judged too complicated for intervention were prepared for surgery. Forty five patients in the present series had an infra-renal aortic occlusion ( Figure 1 ). The remaining 2 patients had juxta-renal lesion.
Preoperative Work-up: Routine preoperative work-up included a complete blood count with hemoglobin percentage and ESR, C-reactive protein, blood sugar, serum bilirubin, liver transaminases, blood urea and serum creatinine, serum electrolyte, fasting lipid profile in a fasting state, and a baseline prothrombin time with International Normalized Ratio (INR). Patients were also screened for major hepatitis viruses and sexually transmitted diseases. In addition to the above, pus from any ulcer or gangrene was sent for culture and sensitivity. In diabetic patients, optimum glycemic control was achieved before surgery with addition of soluble insulin whenever necessary. Surgery was deferred in patients showing growth of organism in their ulcer or gangrene. In patients having co-existent significant coronary artery disease, a cardiologist was consulted. Whenever coronary revascularization was deemed necessary, it preceded peripheral revascularization by at least 3 months, except in one patient who had undergone Percutaneous Transluminal Coronary Angioplasty (PTCA) 2 weeks before the aortobifemoral bypass.
Surgical Procedure: The operations were carried out under high epidural anesthesia on most occasions with sedation by Propofol. The abdominal aorta was approached through a retroperitoneal approach in 27 patients and through a transperitoneal approach in the remaining 20. Careful dissection was carried out around the abdominal aorta between the origins of renal arteries and the inferior mesenteric artery (IMA). In 2 patients with juxta-renal aortic occlusion, control of the suprarenal aorta and the renal arteries was ensured. Having taken proximal control of the aorta, a longitudinal aortotomy was done. Endarterectomy was performed to establish flow from the proximal aorta. An aortic clamp was then placed and proximal anastomosis between the abdominal aorta and the graft was done in an endto-side fashion in 37 patients and end-to-end fashion in the remaining 10. The limbs of the graft were then carefully tunneled to the groin where oblique incisions were placed to expose the femoral arteries. Finally, the distal anastomoses were done between the limbs of the prosthesis and the common femoral arteries (Figure 2 ). In 2 of the 9 patients complaining of impotence, the occluded or stenosed left internal iliac arteries were endarterectomized and anastomosed to the left iliac limb of the graft. A Gelatin-coated Dacron Y-graft prosthesis was used in 43 (5 of which were silvercoated prosthesis) patients while PTFE
Results:
All operations in the present series were completed uneventfully. Mean operation time was 195±23 minutes and mean transfusion volume was 545±27 ml. Mean ICU stay was 3±.5 days. Two patients (4.3%) died in the immediate post-operative periodone 10 hours after the operation and the other on the 2 nd postoperative day. Cause of death in the first case was myocardial infarction. This patient had undergone PTCA with stenting to his right coronary artery 2 weeks earlier. The second death was due to acute renal shut-down leading to renal failure. This patient had chronic kidney disease (CKD). The aortic lesion in this case was juxtarenal requiring a suprarenal aortic clamping. The remaining 45 patients left the hospital in stable conditions with satisfactory surgical outcome. Mean hospital stay was 11±5 days. Before discharge, all patients were evaluated by Duplex ultrasound and measurement of ABI. All patients were asked to return to the hospital for follow-up 1 month, 3 months, 6 months and 1 year after the operation. Further follow-up was at one-year interval. Additional revascularization procedures In 8 patients, concomitant distal bypass was done. Amputations for any non-viable portion of the limb were always carried out. This included disarticulation of one or more toes and Syme's procedure.
Fig.-2: Schematic diagram showing completed aorto-bifemoral bypass grafting for aorto-iliac occlusive disease.
in the distal arterial tree-when required-were planned 4-6 weeks after the discharge.
Wound infection and lymphorrhoea at the groin incision site were the two main immediate postoperative complications. Six patients had lymphorrhoea which was managed by insertion of a drain that was kept in situ until lymph secretion stopped. This strategy was successful in 4 patients while two required reexploration of the groin wound to plicate the lymphatics. Surgical wound infection was found in 8 patients. Six of these were superficial infections and responded to local wound care. The remaining 2 patients required a more expeditious care that included change in antibiotics according to culture and sensitivity report, wound debridement and secondary wound closure. There was no incidence of graft infection in this series.
Twelve patients attended the vascular out-patient department for post-operative follow-up up to 2 years. Graft occlusion was detected in five of these patients 8-23 months after the operation. Three of these patients underwent graft excision with redo Y-graft bypass. The remaining two were treated with extra-anatomic bypass (Axillo-bifemoral) with satisfactory outcome.
Discussion:
Infrarenal abdominal aorta and iliac arteries are among the commonest sites to be involved in atherosclerotic lesions. 5 Stenotic lesions in this area have been classified into 3 main categories depending on the extent of the lesion. Type I disease represents lesion of the aorta and common iliac arteries, type II disease signifies lesions extending into the external iliac arteries and type III means that the lesions have involved the common femoral arteries in addition to the aorta and iliac arteries. 6 Patients with type I lesions may remain asymptomatic due to the development of rich network of collaterals, although many experience buttock claudication. 7 Type II lesions produce symptoms like buttock and thigh claudication and may also cause impotence when it comes to be termed 'Syndrome Leriche'. About two-thirds of the AIOD are type III lesions which typically produce the symptoms of intermittent claudication. Treatment approaches to AIOD have evolved considerably over the last couple of decades thanks to the tremendous development in the field of catheter-based techniques. Many type I lesions are now treated by 'endovascular means. 8 However, bilateral long segment and multifocal lesions with additional femoro-popliteal involvement are better managed surgically than by interventional means. While deciding strategy for AIOD in developing countries, there is the additional issue of cost coming into the equation. Interventional therapy is often more expensive than surgical revascularization. At least 3 of our patients could have been suitable candidates for interventional treatment but were eventually treated by open surgical means on the grounds of cost.
The mean age of the patients in our series was only 46. This, to the best of our knowledge, is the youngest group of aorto-bifemoral bypass recipients. It may be worth mentioning that as many as 5 patients in this series were aged below 30 with another 7 being less than 40 years old. AIOD in such young patients raises important issues related to the pathophysiology of the disease. Is the disease process in these young patients different? Gross examination of the plaques could not answer this question. Detailed histopathological examination of the plaques and the arteries as well as nutritional, immunologic and genetic screening of these patients might give us newer insight into the issue.
AIOD patients with coexistent IHD constitute a contentious issue. We screened all patients for CAD and adopted the strategy of having the critical coronary lesion addressed before peripheral revascularization. We also had the surgery deferred for at least 3 months after any PTCA procedure. These, however, are not universal recommendations. Reports of Y-graft bypass surgery in presence of significant CAD have been published. 9 One of the two mortalities in the present series occurred in a patient who had PTCA with stenting to the right coronary artery 2 weeks prior to the Y-graft bypass. We went for an earlier revascularization in this patient as he was suffering from severe ischemic rest pain with possibility of impending tissue loss. The patient had suffered a massive heart attack in the immediate postoperative period. This could have resulted from an episode of intraoperative hypotension that occurred in this patient resulting in acute stent thrombosis. We recommend particular care in avoiding hemodynamic derangements in this particular group of patient in order to prevent adverse cardiac events. The 4.3% in-hospital mortality in the present series should be among the better results that have been reported for this procedure. [10] [11] [12] [13] [14] [15] [16] [17] [18] We believe that our strategy regarding the coronary lesion have contributed positively to the results.
Juxta-renal aortic occlusion poses a formidable surgical challenge. We operated on 2 patients with such lesions. One of these patients had CKD and died of renal failure in the early postoperative period. Meticulous care during manipulation of the plaques at this critical aortic segment as well as appropriate renal protective measures should be instituted while handling such cases.
Good run-off arteries are important prerequisites for the patency of the Y-graft. To ensure this, any diseased femoro-popliteal segment should be revascularized in the same sitting. Unfortunately, this was not uniformly practiced in all patients of the present series. Generally, we staged the distal bypasses and performed 8 femoro-popliteal bypasses and endarterectomy in the same sitting after the Y-graft procedure. All other distal bypass procedures were performed 2-3 months after the aorto-femoral bypass.
Long-term patency of the Y-graft is an important issue. Previous studies have reported a 10-20% graft occlusion rate at 5 years and 25-30% graft failure at 10 years. 9,10,12.14 Unfortunately, we had only 12 patients adhering to the post-operative follow-up protocol. Thus, data regarding graft patency in this series is inadequate. There was no incidence of graft thrombosis in the immediate post-operative period. The first case of graft occlusion was detected 8 month after surgery. This patient had occlusive disease in the distal arterial tree which was not revascularized during the aortofemoral bypass. There were 4 additional cases of graft failure within 2 years after the surgery. All these patients presented with recurring claudication. Cases of occluded grafts were managed with re-do Y-graft bypass in 3 patients and extra-anatomic bypass in 2.
The importance of lifestyle modification in patients with AIOD cannot be over-emphasized. Cessation of smoking and meticulous control of diabetes, hypertension and serum lipid levels are necessary.
Regular walking and dietary modifications are also important. The patients often fail to understand the true importance of these measures. Many patients go back to their old smoking habit, which lead to progression of distal disease and recurrent symptoms. Proper counseling at the time of discharge may help in the implementation of the lifestyle modifications in these patients.
